Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$22,978,592
-$2,033,026 QoQ
Shares Held
181,879
+1.3% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.55%
of 13F equity value
Holder Rank
#311
of 2,266 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 74%
Shared 0%
None 26%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MARTINGALE ASSET MANAGEMENT L P holds $269,326,033 across 9 Drug Manufacturers - General names. GILD ranks #6 (8.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
40,766 | $48,895,967 | |
| 2 | JNJ |
Johnson & Johnson
|
184,122 | $46,761,464 | |
| 3 | ABBV |
AbbVie Inc.
|
160,685 | $40,434,773 | |
| 4 | MRK |
Merck & Co., Inc.
|
274,491 | $35,272,093 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
520,919 | $30,015,352 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
181,879 | $22,978,592 | |
| 7 | AMGN |
Amgen Inc
|
62,656 | $22,688,990 | |
| 8 | PFE |
Pfizer Inc
|
477,198 | $11,490,927 |
All Filings in GILD
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,978,592 | 181,879 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $25,011,618 | 179,462 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $23,801,863 | 193,921 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $19,177,248 | 172,768 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $21,535,056 | 194,237 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $22,037,769 | 196,678 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $21,199,099 | 229,502 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $21,421,958 | 255,510 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $20,824,644 | 303,522 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $23,065,765 | 314,891 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $27,383,567 | 338,027 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $27,167,923 | 362,529 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $29,247,525 | 379,493 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $32,919,177 | 396,760 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $34,024,758 | 396,328 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $26,781,171 | 434,125 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $26,871,712 | 434,747 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $27,012,177 | 454,368 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $18,575,235 | 255,822 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,198,276 | 17,155 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||